The comparative distribution of Leu-enkephalin and an enkephalin precursor fragment, BAM-22P, was studied in the rat telencephalon using immunocytochemical procedures. Although the enkephalins have previously been localized to telencephalic neurons, the use of high doses of colchicine in the present study has permitted the visualization of widespread enkephalin-containing systems in cortical-limbic regions. Rats were treated intraventricularly with colchicine (300 to 400 pg) to enhance the visualization of neuronal perikarya. Leu-enkephalin immunoreactivity was noted in perikarya as well as processes of neurons in many telencephalic regions including the olfactory bulb, parolfactory areas, olfactory tubercle, basal ganglia, nucleus accumbens, septal nuclei, amygdala, hippocampal formation, and several paleocortical regions such as the piriform, entorhinal, and cingulate cortex, as well as regions of the frontal, parietal, and occipital neocortex. In the majority of regions investigated, analysis of sections adjacent to those processed for Leu-enkephalin histochemistry showed BAM-22P immunoreactivity to be localized to perikarya and processes in the same region. These results suggest that brain enkephalin-positive neurons may possess mechanisms for enkephalin biosynthesis similar to those found in adrenal medullary enkephalin cells.
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presence of immunoassayable material (Yang et al., 1977;  ' To whom correspondence should be addressed. Miller et al., 1978) . Subsequent studies on rats either 844 The Journal of Neuroscience Telencephalic Enkephalin 845 with or without colchicine pretreatment have succeeded in visualizing a few enkephalin-positive terminals and fibers in some cortical areas (Sar et al., 1978; Wamsley et al., 1980) and enkephalin-positive cells appearing sporadically in layers II to VI in neocortex (Finley et al., 1981) and more densely in layers II to III of the entorhinal cortex (Gall et al., 1981) . However, because of the problem of immunocytochemical staining sensitivity, these observations may not account for the full extent of cortical-limbic enkephalin pathways. In the present study, utilization of very high doses of colchicine as pretreatment has permitted the visualization of extensive systems of cortical-limbic enkephalin pathways. Furthermore, in order to provide evidence regarding the presence of the enkephalin precursor processing system in cortical-limbic neuronal systems, we also determined the distribution of an enkephalin precursor fragment, BAM-22P, from bovine adrenal medulla (Mizuno et al., 1980) ) (Fig. 1 ).
Materials and Methods
Adult male Sprague-Dawley rats were treated with varying amounts of colchicine (50, 100, 200, 300, 350 , and 400 pg) injected as a bolus (10 ~1) into the right lateral ventricle to enhance cell body visualization. These rats were sacrificed at 24 or 48 hr after treatment. Each animal was anesthetized with sodium pentobarbital (50 mg/ml, i.p.), the chest cavity was exposed, and the cardiovascular system was flushed with 50 ml of ice-cold normal saline. For fixation, ice-cold 4% neutral buffered formaldehyde was systemically perfused at 140 mm Hg for 30 min. The brain was removed and either postfixed in the same fixative for 30 min and immersed in 15% sucrose, or was directly immersed in 15% sucrose and then stored overnight at 4°C. Freezing was achieved by the immersion of the brains in -40°C isopentane for 30 to 40 set and then embedding in powdered dry ice. Frontal, parasagittal, and horizontal sections of 20 pm thickness were obtained using a cryostat (-20°C) and were stored at -70°C.
Immunocytochemical staining with primary antisera against Leu-enkephalin (Watson et al., 1977b) and BAM-22P (antiserum "Tristan; " Hollt et al., 1981) was carried out as follows. Sections were air-dried and incubated (37°C) with normal goat serum (NGS) (Grand Island Biological Co.) at l/30 dilution for 5 to 10 min and then with the primary rabbit antiserum (Table I) for 1 hr at 37"C, and overnight (approximately 24 hr) at 4°C. On some sections, for control purposes, each antiserum was pre-adsorbed with 25 to 50 PM peptide (Leu-enkephalin, Met-enkephalin, BAM-22P, or dynorphin-17) in a crossblocking paradigm to ensure antibody specificity. The next day, the sections were thoroughly washed in 0.02 M phosphate-buffered saline (PBS) and incubated (37°C) with NGS (5 to 10 min), and then with goat-anti-rabbit serum (Sternberger-Meyer) at l/100 dilution for 30 min at 37"C, and overnight (approximately 24 hr) at 4°C. On the 3rd day, the sections were washed in PBS and incubated (37°C) with NGS, then with rabbit anti-horseradish peroxidase (HRP) serum at l/200 dilution for 40 min at 37°C. These were then washed in PBS and subsequently were incubated with HRP enzyme (Sigma, type VI), 4 pg/ml, for 40 min at 37°C. Again, the sections were washed in PBS and were immersed in a solution of 0.125 mg/ml of diaminobenzidine (Sigma) and 0.03% HZOz, for 15 min. Then they were washed in distilled water, briefly osmicated (2% Os04), rewashed, dehydrated through increasing concentrations of ethanols and xylenes, and mounted with Permount. Observations and photography were made using a Leitz Orthoplan microscope. The Leu-enkephalin antiserum was purified in an affinity chromatography column with cyanogen bromideactivated Sepharose-4B (March et al., 1974) onto which Leu-enkephalin was linked in order to purify IgG molecules with significant affinity toward the antigen. This approach has the added benefit of concentrating specific antibodies while reducing the nonspecific antibody content. Removal of the nonspecific IgG molecules reduces nonspecific binding to tissue and greatly reduces background. Thus the visible signal is greatly enhanced (see Watson and Akil, 1981 , for a review).
Results
Immunoreactive Leu-enkephalin perikarya and processes are widely distributed throughout telencephalic cortical-limbic structures. These include: olfactory bulb, tuberculum olfactorium, piriform cortex, nucleus accumbens, diagonal band of Broca, septal nuclei, nucleus caudate-putamen, globus pallidus, several amygdaloid nuclei, entorhinal cortex, hippocampal formation, cingulate cortex, and several neocortical areas (Fig. 2, A to E). Most of these areas also contain BAM-22P-immunoreactive neurons in anatomical position similar to that of Leu-enkephalin neurons (Figs. 4 and 6 ). In cortex, Leuenkephalin immunoreactivity often appeared more concentrated in the initial segment of the axon than in the perikaryon (Fig. 6C) , whereas BAM-22P immunoreactivity appeared mainly in the perikaryon (Fig. 6D) . Furthermore, Leu-enkephalin and BAM-22P completely blocked the immunoreactive signal obtained by Leu-enkephalin and BAM-22P antisera, respectively. Blocking was selective since Met-and Leu-enkephalin did not block the signal obtained with BAM-22P antiserum, nor did BAM-22P block the immunoreactivity obtained using anti-Leu-enkephalin serum. Furthermore, dynorphin-17 did not block the immunoreactive signal obtained using either leu-enkephalin or BAM-22P antisera.
In the olfactory bulb, many small immunoreactive perikarya form a ring-like cluster of cells several layers thick around the intermediate olfactory tract into which immunoreactive processes project. The perikarya are distributed within the external, lateral, dorsal, and medial parts of the anterior olfactory nucleus (Figs. 2A and 3A) . Fine varicose immunoreactive processes also occur in discrete clusters in the glomerular layer of the olfactory bulb (Fig. 30 ). More caudally, small perikarya can also be seen in the tuberculum olfactorium and adjoining piriform cortex as a continuous band of cells that stretches laterally and dorsally to the rhinal fissure (Figs. 2B and 3C) . Furthermore, in the tuberculum olfactorium, perikarya are seen in both superficial and deep cortical layers, whereas in the piriform cortex most perikarya occur in layer II. Very few perikarya exist dorsal to the rhinal fissure and, when encountered, are faintly immunoreactive. The nucleus accumbens, dorsal to the tuberculum olfactorium, also contains dense immunoreactive processes and terminals and some perikarya in regions medial to the anterior commissure (Fig. 2B ). Continuous with perikarya in the tuberculum olfactorium are scattered immunoreactive perikarya as well as processes in the region of the diagonal band of Broca and the medial parolfactory area (Fig. 2B ).
More caudally, in the septal region, immunoreactive perikarya and processes are situated in the lateral and, to a lesser extent, in the medial septum (Figs. 2C and 5). In the lateral septum, a particularly dense cluster of immunoreactive terminals is present in the ventrolateral region (Fig. 5B ). The nucleus caudate-putamen contains small enkephalin-positive perikarya and fine, patchy varicose processes (Figs. 2, B to D, and 4A) . The majority of these perikarya are situated adjacent to the globus pallidus. A very dense network of fibers and fine terminal processes outline the globus pallidus so heavily that this area is clearly distinguishable at low magnifications (Figs. 2CandD, and4A) .
In the piriform cortex, many small enkephalin-positive perikarya outline the amygdaloid complex of nuclei (Figs. 20 and 6) . At this level, the majority of cortical cells are present in layer II. Medial to the piriform cortex, the cortical amygdaloid nucleus (periamygdaloid cortex) is densely populated with immunoreactive cells (Fig. 20) .
In the amygdala, perikarya are scattered in several nuclei, the most prominent of which is the central nucleus, which appears to be densely populated with immunoreactive cells and fibers (Figs. 20 and 7A) . Some perikarya and fibers also exist in anterior, medial, lateral, basal, and intercalated amygdaloid nuclei (Fig. 7B ).
In the entorhinal cortex, immunoreactive Leu-enkephalinergic perikarya are situated in both lateral and medial cortical areas. In the lateral entorhinal cortex, these cells appear in two bands in layers II and III and end dorsally at or just beyond the rhinal fissure in the perirhinal area (Figs. 2E, and 8, A and B) . From these entorhinal cortical cells, immunoreactive processes appear to project through the subiculum and into the hippocampal formation (Figs. 2E and 8, A and C). In the hippocampal formation, fine immunoreactive fibers and terminals are situated within the stratum moleculare of the dentate gyrus (containing the dendrites of granule cells). A few scattered immunoreactive perikarya are also seen in the stratum granulosum of the dentate gyrus (Figs. 2E and 8A) . Fine varicose immunoreactive processes are located on the apical side of the stratum pyramidale (areas CA2 and CA3) of the hippocampus proper, which appear to correspond to the mossy fiber projections of granule cells (Figs. 2E and 8A ).
In the cingulate cortex, small immunoreactive perikarya are seen to be widely scattered throughout its rostral-caudal extent in layers II to VI (Fig. 2, B to E). In neocortex, immunoreactive perikarya were observed in the frontal, parietal, and occipital cortex, where they appear to be distributed primarily in layer II and to a lesser extent in deeper layers (Figs. 2, A to E, and 9).
Discussion
In this study, colchicine-treated rates were used to investigate the distribution of Leu-enkephalin neurons in telencephalic cortical-limbic structures. Colchicine treatment enhanced the visualization of perikarya presumably by inhibiting microtubule formation and thus axonal transport of synthesized material (Norstrom et al, 1971) . Colchicine treatment also enhanced the visualization of the dendrites, initial segments of axons, and axonal projection pathways. The best results were obtained with 300 to 400 pg of colchicine administered 24 or 48 hr antemortem; these treatments allowed the visualization in cortical-limbic areas of the smallest enkephalinergic perikarya which were not detectable in the absence or inergic systems are not included. The number in the lower left-hand corner of each drawing indicates the distance of that section from the vertical zero plane (de Groot, 1959; Pellegrino et al., 1979) . aaa, anterior amygdaloid area; abl, basal amygdaloid nucleus; acb, nucleus accumbens, lateral parolfactory area; ace, central amygdaloid nucleus; ace, cortical amygdaloid nucleus; al, lateral amygdaloid nucleus; ame, medial amygdaloid nucleus; bca, bed nucleus of the anterior commissure; bst, bed nucleus of the stria terminalis; ca, anterior commissure; ca. with lower amounts of colchicine. Although there is evidence that direct intracerebral injection of colchicine can result in neuronal damage (Goldschmidt and Steward, 1982) , examination of Nissl-stained tissue in the present study did not reveal evidence of neuronal damage outside of the cannula track resulting from intraventricular colchicine administration.
Comparison of the distribution of Leu-enkephalin and an enkephalin-precursor fragment, BAM-22P, showed these two immunoreactivities to be similarly distributed in various telencephalic regions, suggesting substantial similarity between the proenkephalin precursor structure found in adrenal gland (Gubler et al., 1982; Noda et al., 1982) and that in rat brain. In most areas studied for Leu-enkephalin, adjacent section analysis showed BAM-22P to be present in neurons of the same region. Whether Leu-enkephalin and BAM-22P immunoreactivity are colocalized within the same neurons is currently being studied. However, in the present study, the thickness of the sections (20 ,um) precluded co-localization studies, since many Leu-enkephalin-positive neurons are smaller than 20 pm in diameter (except for hypothalamic magnocellular and medullary gigantocellular neurons which may contain enkephalin). Appropriate cross-blocking studies showed each antiserum to be specific for its particular peptide. Neither Leu-nor Met-enkephalin blocked the immunoreactivity observed using the BAM-22P antiserum. Likewise, BAM-22P did not block the Leu-enkephalin-immunoreactive signal. Finally, neither immunoreactivity was blocked by dynorphin-17. The majority of telencephalic Leu-enkephalin-immunoreactive neurons observed in this study are small bipolar or multipolar neurons, although larger enkephalincontaining neurons exist in the hypothalamic magnocellular nuclei (Micevych and Elde, 1980) and the medullary gigantocellular reticular nucleus (Finley et al., 1981) . Leuenkephalin perikarya were seen in olfactory bulb nuclei, the tuberculum olfactorium, nucleus accumbens, septal nuclei, nucleus caudate putamen, amygdaloid nuclei, hippocampal formation, and limbic-associated cortical areas including the piriform, periamygdaloid, entorhinal, and cingulate cortex, as well as several neocortical regions.
Most previous studies of enkephalin localization have not described many of the limbic-associated cortical enkephalin systems (Elde et al., 1976; Hokfelt et al, 1977a; Simantov et al., 1977; Watson et al., 1977a) . In subsequent studies utilizing colchicine, relatively few enkephalinpositive fibers and terminals have been visualized in cortical areas (Sar et al., 1978; Wamsley et al., 1980) . More recently, Finley et al. (1981) have described several cortical and limbic regions where enkephalin perikarya previously were not reported. These include the olfactory bulb, tuberculum olfactorium, some amygdaloid nuclei, hippocampus, cingulate cortex, and neocortex. In this study, we report additional areas of enkephalin localization, including perikarya situated in several regions of the anterior olfactory nucleus, and in axonal projections within the intermediate olfactory tract, which appear to . arise from the latter perikarya. However, we were able to seen in deeper cortical laminae, the majority are present see only occasional immunoreactive periglomerular cells in layer II. A row of small immunoreactive perikarya was of the bulb as reported (Finley et al., 1981) . Furthermore, observed in the piriform cortex extending laterally to the we have noted a more organized cortical arrangement of rhinal fissure, with occasional perikarya seen dorsal to the enkephalin perikarya than previously reported. Imthis fissure in the perirhinal area. In the entorhinal munoreactive perikarya were seen in the piriform, peri-cortex, immunoreactive neurons were noted in layers II amygdaloid, and entorhinal cortical, and several neocortand III and appeared to project toward the subiculum. ical regions. Although some of these perikarya are Gall et al. (1981) the dentate gyrus to hippocampal fields CA3 and CA2 (Blackstad et al., 1970; Swanson et al., 1978) . No fiber immunoreactivity was noted in field CAL In sum, we have noted enkephalin and BAM-22P immunoreactivity in many structures of the limbic system, including olfactory-associated areas, septum, amygdala, hippocampus, and paleocortex. We have also noted widespread enkephalin and BAM-22P immunoreactivity in other limbic-related areas within the diencephalon and mesencephalon, which will be the subject of future reports.
The physiological roles played by the enkephalins and other opioid peptides are still being investigated. The enkephalins have been implicated in such central nervous system regulatory functions as nociception (Belluzzi et al., 1976; Duggan et al., 1976; Leyben et al., 1976) , control of respiration and heart rate (Cowan et al., 1976; Florez and Mediavilla, 1977) , neuroendocrine control (Lien et al., 1976; DuPont et al., 1977; May et al., 1979a, b) , euphoria and drive-reduction reward (Belluzzi and Stein, 1977) , memory (Collier et al., 1981) , and attention (Davis et al., 1980; Arnsten et al., 1981; Lewis et al., 1981a) . Electrophysiological studies with the enkephalins seem to demonstrate an inhibitory role (i.e., depression of firing rates of responsive cells) in many brain regions, for example, spinal cord, locus ceruleus, periaqueductal gray, thalamus, and caudate, cerebral, and cerebellar cortices (Bradley et al., 1976; Hill et al., 1976; Frederickson and Norris, 1976; Zieglgansberger and Fry, 1976; Nicoll et al., 1977; Young et al., 1977; Satoh et al., 1979; Zieglgansberger and Tulloch, 1979) . However, the enkephalins appear to have a stimulatory role in the hippocampus, which might be due to their inhibition of an inhibitory interneuron (Nicoll et al., 1977; Mueller et al., 1979; Jensen et al., 1979; Zieglgansberger et al., 1979; Dunwiddie et al., 1980; Lee et al., 1980) . Our findings, as well as those of Gall et al. (1981) , indicate that the mossy fiber enkephalinergic system might be a more appropriate site to study the synaptic effects of the hippocampal enkephalins than field CAl, where most previous studies of hip- Figure 7 . Amygdala. A shows Leu-enkephalin-positive peri-pocampal enkephalin pharmacology have focused. karya in the central amygdaloid nucleus. Other amygdaloid As noted above, excitatory opioid effects in the central nuclei with Leu-enkephalin immunoreactivity include the in-nervous system may occur indirectly, as a result of distercalated amygdaloid nucleus (B). Bars = 50 pm.
inhibition (Nicoll et al., 1980) . The latter investigators, studying the phenomenon of disinhibition in the turtle olfactory bulb, have shown that D-Ala-Met-enkephalinnergic systems of the hippocampal formation. Our results amide acts on the dendritic reciprocal synapses causing agree with their observations, with the possible exception a dendrodendritic inhibition of mitral cells. Because olthat we were able to see only occasional immunoreactive factory centrifugal fibers make indirect contacts with perikarya within the stratum granulosum of the dentate mitral cells, perhaps via inhibitory interneurons (Halaz gyrus and even fewer in the stratum pyramidale of hipet al., 1978 hipet al., ), Nicoll et al. (1980 have raised the possibility pocampal area CA1 or in the subiculum. The enkephalithat some of these centrifugal fibers might contain ennergic projections to the stratum moleculare of the den-kephalin. In support of this suggestion, we have noted tate gyrus appear to originate from perikarya in the Leu-enkephalin-immunoreactive fibers in the intermedientorhinal cortex, reaching their targets via the perforant ate olfactory tract, perhaps representing projections of path. This system appears to correspond to the entorhiimmunoreactive perikarya in the anterior olfactory nunal-hippocampal projectional system described using cleus or other olfactory-related areas. These fibers appear tract tracing methods (Hjorth-Simonsen, 1972; Steward, to ascend in the bulb and distribute predominantly to 1976). The second, intrahippocampal enkephalinergic the glomerular layer where they may interact with inhibsystem, also described by Gall et al. (1981) , corresponds itory periglomerular cells or possibly the dendrites of to the mossy fiber projection from the granule cells of mitral cells. These findings are complemented by the Khachaturian et al. Vol. 3, No. 4, Apr. 1983 Figure 8. Entorhinal cortex-hippocampal formation. A shows a two-column wide photomontage of the entorhinal-hippocampal region in a frontal view. Leu-enkephalin-immunoreactive neurons in the entorhinal cortex (ent; magnified in B) seem to project via the perforant path (p; magnified in C) to the stratum moleculare (m) of the dentate gyrus. Other areas of Leu-enkephalin immunoreactivity include the hilus (h) of the dentate gyrus and mossy fiber projections (arrow) to the hippocampus. I$, hippocampal fissure; r-f rhinal fissure; s, subiculum. Bars: A, 200 pm; B and C, 50 pm. demonstration of relatively dense opiate receptor binding in those bulb layers where such reciprocal dendrodendritic synapses occur (Nadi et al., 1980) . Some correspondence between enkephalin distribution and opiate receptor density has been noted previously in brains from different animals (Atweh and Kuhar, 1977; Simantov et al., 1977) . The existence of several types of opiate receptors with different distributional patterns in the brain is well established (Lord et al., 1976; Chang and Cuatrecasas, 1979; Goodman et al., 1980; Lewis et al., 1981a, b) 
